Reply to: “Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?”

Reply to: “Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?”

By: Alexandra de Leon Date: February 1st, 2021

Stay Connected

Other Publications

More events you may be interested in.

Custom Link To Another Page Goes Here